Pancreatic adenocarcinoma: The actual 5-year survivors
Pancreatic adenocarcinoma: The actual 5-year survivors
复制标题
DOI：
10.1007/s11605-007-0384-8
复制
发表时间：
2008-04-01
影响因子：
3.2
通讯作者：
Allen, Peter J.
中科院分区：
文献类型：
--
作者：
Ferrone, Cristina R.;Brennan, Murray F.;Allen, Peter J.
背景：大多数关于胰腺癌切除术患者的报告估计（精算）5年生存率。实际的5年生存率很少描述，与长期生存率相关的因素没有很好地described.Methods前瞻性维护的数据库审查确定了618例胰腺癌切除术1/1983-1/2001之间。患者，肿瘤，治疗相关变量进行了评估，他们与5年survival.Results有75例患者生存>5年切除术后（75 618，12%），18例患者生存>10年（18 352，5%）。患者年龄、性别和肿瘤部位与5年生存率无关，而早期美国癌症联合委员会（AJCC）分期（p
Background Most reports of patients undergoing resection for pancreatic adenocarcinoma report estimated (actuarial) 5-year survival rates. Actual 5-year survival is rarely described, and factors associated with long-term survival are not well described.Methods Review of a prospectively maintained database identified 618 patients who underwent resection for pancreatic adenocarcinoma between 1/1983-1/2001. Patient, tumor, and treatment-related variables were assessed for their association with 5-year survival.Results There were 75 patients who survived >5 years after resection (75 out of 618, 12%), and 18 patients who survived >10 years (18 out of 352, 5%). Patient age, gender, and tumor location were not associated with 5-year survival, whereas early American Joint Committee on Cancer (AJCC) stage (p